<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01621061</url>
  </required_header>
  <id_info>
    <org_study_id>01-7/219</org_study_id>
    <nct_id>NCT01621061</nct_id>
  </id_info>
  <brief_title>Sleep Related Breathing Disturbances and High Altitude Pulmonary Hypertension in Kyrgyz Highlanders</brief_title>
  <official_title>Sleep Apnea and High Altitude Pulmonary Hypertension in Kyrgyz Highlanders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center of Cardiology and Internal Medicine, Kyrgyzstan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      High altitude pulmonary hypertension, a form of altitude illness that occurs in long-term
      residents at altitudes &gt;2500 m, is characterized by dyspnea, hypoxemia, impaired exercise
      performance and hypertension in the pulmonary circulation. Whether sleep related breathing
      disturbances, common causes of nocturnal hypoxemia in lowlanders, are also prevalent in
      highlanders and promote pulmonary hypertension in highlanders is unknown. Therefore, the
      current study will investigate whether highlanders with high altitude pulmonary hypertension
      have a greater prevalence of sleep apnea than healthy highlanders and lowlanders.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sleep related breathing disturbances</measure>
    <time_frame>4 months</time_frame>
    <description>Nocturnal oxygen saturation and apnea/hypopnea index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulmonary artery pressure</measure>
    <time_frame>4 months</time_frame>
    <description>Echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea</measure>
    <time_frame>4 months</time_frame>
    <description>NYHA functional class</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vigilance</measure>
    <time_frame>4 months</time_frame>
    <description>Psychomotor vigilance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise performance</measure>
    <time_frame>4 months</time_frame>
    <description>6 min walk test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary function</measure>
    <time_frame>4 months</time_frame>
    <description>Spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral oxygen saturation</measure>
    <time_frame>4 months</time_frame>
    <description>Near-infrared spectroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mountain sickness</measure>
    <time_frame>4 months</time_frame>
    <description>Quinghai chronic mountain sickness score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generic quality of life</measure>
    <time_frame>4 months</time_frame>
    <description>SF-36 quality of life questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease specific quality of life</measure>
    <time_frame>4 months</time_frame>
    <description>Kansas City Cardiomyopathy questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective sleepiness</measure>
    <time_frame>4 months</time_frame>
    <description>Epworth sleepiness scale</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">125</enrollment>
  <condition>High Altitude Pulmonary Hypertension</condition>
  <condition>Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>High altitude pulmonary hypertension</arm_group_label>
    <description>Highlanders with high altitude pulmonary hypertension</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High altitude control</arm_group_label>
    <description>Healthy highlanders</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low altitude control</arm_group_label>
    <description>Healthy lowlanders</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Highlanders with high altitude pumonary hypertension living at an altitude of 2500-4000 m;
        healthy highlanders living at an altitude of 2500-4000 m; healthy lowlanders living at an
        altitude of &lt;1000 m.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  high altitude pulmonary hypertension confirmed by clinical presentation and systolic
             pulmonary artery pressure &gt;50 mmHg measured by echocardiography at altitude of
             residence.

          -  healthy subjects (high altitude controls)

          -  Both genders

          -  Age &gt;16 y

          -  Kyrgyz ethnicity

          -  born, raised and currently living at &gt;2500 m

          -  healthy subjects currently living at &lt;1000 m (low altitude controls)

        Exclusion criteria:

          -  Pulmonary hypertension from other causes, in particular from left ventricular failure
             as judged clinically and by echocardiography

          -  excessive erythrocytosis

          -  other coexistent disorders that may interfere with the cardio-respiratory system and
             sleep

          -  regular use of medication that affects control of breathing

          -  heavy smoking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Konrad E Bloch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Talant Sooronbaev, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Center of Cardiology and Internal Medicine, Kyrgyzstan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Center for Cardiology and Internal Medicine</name>
      <address>
        <city>Bishkek</city>
        <zip>720040</zip>
        <country>Kyrgyzstan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kyrgyzstan</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 13, 2012</study_first_submitted>
  <study_first_submitted_qc>June 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2012</study_first_posted>
  <last_update_submitted>May 14, 2014</last_update_submitted>
  <last_update_submitted_qc>May 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 15, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Zurich</investigator_affiliation>
    <investigator_full_name>Konrad E. Bloch</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>high altitude illness</keyword>
  <keyword>pulmonary hypertension</keyword>
  <keyword>sleep apnea</keyword>
  <keyword>hypoxia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Altitude Sickness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

